Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02559609 | BUCCOLAM | NEURAXPHARM PHARMACEUTICALS, S.L. | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 10 MG | Marketed |
| 02559595 | BUCCOLAM | NEURAXPHARM PHARMACEUTICALS, S.L. | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 7.5 MG | Marketed |
| 02559587 | BUCCOLAM | NEURAXPHARM PHARMACEUTICALS, S.L. | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Marketed |
| 02559579 | BUCCOLAM | NEURAXPHARM PHARMACEUTICALS, S.L. | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 2.5 MG | Marketed |
| 02243254 | APO-MIDAZOLAM INJECTABLE 5 MG/ML | APOTEX INC | Liquid | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02243934 | MIDAZOLAM INJECTION | NOVOPHARM LIMITED | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02243935 | MIDAZOLAM INJECTION | NOVOPHARM LIMITED | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02383586 | MIDAZOLAM INJECTION | MYLAN PHARMACEUTICALS ULC | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 1 MG | Cancelled Pre Market |
| 02383594 | MIDAZOLAM INJECTION | MYLAN PHARMACEUTICALS ULC | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Cancelled Pre Market |
| 02241753 | MIDAZOLAM INJECTION BP | HOSPIRA HEALTHCARE ULC | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 1 MG | Cancelled Pre Market |
| 02241754 | MIDAZOLAM INJECTION BP | HOSPIRA HEALTHCARE ULC | Solution | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Cancelled Pre Market |
| 02242653 | PMS-MIDAZOLAM | PHARMASCIENCE INC | Liquid | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 1 MG | Cancelled Pre Market |
| 02242654 | PMS-MIDAZOLAM | PHARMASCIENCE INC | Liquid | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Cancelled Pre Market |
| 00784516 | VERSED INJ 1MG/ML | HOFFMANN-LA ROCHE LIMITED | Liquid | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 00766011 | VERSED INJ 5MG/ML | HOFFMANN-LA ROCHE LIMITED | Liquid | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) 5 MG | Cancelled Post Market |